National Cancer Institute; Notice of Closed Meetings, 7466-7467 [2014-02587]
Download as PDF
7466
Federal Register / Vol. 79, No. 26 / Friday, February 7, 2014 / Notices
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.12A, Bethesda, MD
20892–4874, 301–594–3998, trempemo@
mail.nih.gov.
Name of Committee: National Institute of
General Medical Sciences Initial Review
Group; Training and Workforce Development
Subcommittee—D.
Date: March 13–14, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Rebecca H. Johnson, Ph.D.,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3An.18C, Bethesda, MD
20892–4874, 301–594–2771, JohnsoRe@
nigms.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.375, Minority Biomedical
Research Support; 93.821, Cell Biology and
Biophysics Research; 93.859, Pharmacology,
Physiology, and Biological Chemistry
Research; 93.862, Genetics and
Developmental Biology Research; 93.88,
Minority Access to Research Careers; 93.96,
Special Minority Initiatives, National
Institutes of Health, HHS).
Dated: February 3, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–02584 Filed 2–6–14; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
mstockstill on DSK4VPTVN1PROD with NOTICES
National Cancer Institute; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications/
contract proposals and the discussions
could disclose confidential trade secrets
or commercial property such as
patentable material, and personal
information concerning individuals
associated with the grant applications,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus
R03/R21: Tumor Immunology.
Date: March 5–6, 2014.
Time: 6:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Mar<15>2010
17:17 Feb 06, 2014
Jkt 232001
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Robert Bird, Ph.D., Chief,
Resources and Training Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W110, Bethesda, MD 20892–
8328, 240–276–6344, birdr@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; NCI
Omnibus—Cancer Biology 1.
Date: March 6–7, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W242,
Bethesda, MD 20892–9750, 240–276–6372,
zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel;
Collaborative Research in Integrative Cancer
Biology.
Date: March 13, 2014.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W242, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Zhiqiang Zou, MD, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W242,
Bethesda, MD 20892–9750, 240–276–6372,
zouzhiq@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Awards for
Research on Imaging and Biomarkers for
Early Cancer Detection.
Date: March 17, 2014.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
2W914, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Thomas A. Winters, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W412,
Rockville, MD 20892–2750, 240–276–6386,
twinters@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Prevention.
Date: March 19, 2014.
Time: 7:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center 5701, Marinelli Road,
Bethesda, MD 20852.
Contact Person: Clifford Schweinfest,
Ph.D., Scientific Review Officer, Special
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W108, Bethesda, MD 20892–9750,
240–276–6343, schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; BiosensorBased Core Needles for Tumor Biopsy.
Date: March 19, 2014.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Donald L. Coppock, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center, Room 7W260,
Bethesda, MD 20892, 240–276–6382,
donald.coppock@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Omnibus—
Drug Delivery/Imaging/Biotechnology.
Date: March 20–21, 2014.
Time: 7:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Courtyard Marriott Washingtonian
Center, 204 Boardwalk Place, Gaithersburg,
MD 20878.
Contact Person: Gerald G. Lovinger, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W266,
Rockville, MD 20850–9750, 240–276–6385,
lovingeg@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel, Cancer
Therapy (Omnibus).
Date: March 27–28, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Gaithersburg Marriott
Washingtonian Center, 9751 Washingtonian
Boulevard, Gaithersburg, MD 20878.
Contact Person: Caron A Lyman, Ph.D.,
Chief, Research Programs Review Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W126, Bethesda, MD 20892–
9750, 240–276–6348, lymanc@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Drug
Reformulation.
Date: March 27, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract
proposals.
Place: Hilton Garden Inn Washington DC/
Bethesda, 7301 Waverly Street, Bethesda, MD
20814.
Contact Person: Thomas M. Vollberg,
Ph.D., Scientific Review Officer, Special
Review and Logistics Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W412, Bethesda, MD 20892–9750,
240–276–6341, vollbert@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Career
E:\FR\FM\07FEN1.SGM
07FEN1
mstockstill on DSK4VPTVN1PROD with NOTICES
Federal Register / Vol. 79, No. 26 / Friday, February 7, 2014 / Notices
Development Awards (PAR 12–050, PAR 12–
062).
Date: April 1, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
7W032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Lynn M. Amende, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W112, Bethesda, MD 20892–9750,
240–276–6345, amendel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Career
Development Awards (PAR 12–121).
Date: April 2, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Cancer Institute Shady
Grove, 9609 Medical Center Drive, Room
4W032, Rockville, MD 20850, (Telephone
Conference Call).
Contact Person: Lynn M. Amende, Ph.D.,
Scientific Review Officer, Resources and
Training Review Branch, Division of
Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive,
Room 7W112, Bethesda, MD 20892–9750,
240–276–6345, amendel@mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Biology–3.
Date: April 17–18, 2014.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Bethesda North Marriott Hotel &
Conference Center, 5701 Marinelli Road,
Bethesda, MD 20852.
Contact Person: Viatcheslav A
Soldatenkov, MD, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch,
Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W254, Bethesda, MD 20892–
8329, 240–276–6378, soldatenkovv@
mail.nih.gov.
Name of Committee: National Cancer
Institute Special Emphasis Panel; Cancer
Detection, Diagnosis, and Treatment
Technologies for Global Health.
Date: April 29–30, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Washington/Rockville, 1750
Rockville Pike, Rockville, MD 20852.
Contact Person: Adriana Stoica, Ph.D.,
Scientific Review Officer, Special Review
and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH,
9609 Medical Center Drive, Room 7W234,
Bethesda, MD 20892–9750, 240–276–6368,
Stoicaa2@mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
deainfo.nci.nih.gov/advisory/sep/sep.htm,
where an agenda and any additional
information for the meeting will be posted
when available.
VerDate Mar<15>2010
17:17 Feb 06, 2014
Jkt 232001
(Catalogue of Federal Domestic Assistance
Program Nos. 93.392, Cancer Construction;
93.393, Cancer Cause and Prevention
Research; 93.394, Cancer Detection and
Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology
Research; 93.397, Cancer Centers Support;
93.398, Cancer Research Manpower; 93.399,
Cancer Control, National Institutes of Health,
HHS)
Dated: February 3, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–02587 Filed 2–6–14; 8:45 am]
BILLING CODE 4140–01–P
7467
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892.
Contact Person: Raymond Jacobson, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5858,
MSC 7849, Bethesda, MD 20892, 301–996–
7702, jacobsonrh@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS).
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Dated: February 3, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2014–02588 Filed 2–6–14; 8:45 am]
Center for Scientific Review; Notice of
Closed Meetings
BILLING CODE 4140–01–P
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict Panel 1: Population Sciences and
Epidemiology.
Date: February 19–20, 2014.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892,
(Virtual Meeting).
Contact Person: Karin F Helmers, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3144,
MSC 7770, Bethesda, MD 20892, (301) 254–
9975, helmersk@csr.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Career
Development Awards in Tobacco Control
Regulatory Research.
Date: February 19, 2014.
Time: 9:30 a.m. to 6:30 p.m.
Agenda: To review and evaluate grant
applications.
PO 00000
Frm 00046
Fmt 4703
Sfmt 4703
National Institutes of Health
National Institute of General Medical
Sciences; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
General Medical Sciences Special Emphasis
Panel; Peer Review of R24 Grant
Applications.
Date: February 20, 2014.
Time: 10:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Natcher Building, 45 Center Drive, Room
3An.18, Bethesda, MD 20892.
Contact Person: Lisa A. Newman, SCD,
Scientific Review Officer, Office of Scientific
Review, National Institute of General Medical
Sciences, National Institutes of Health, 45
Center Drive, Room 3s.18A, Bethesda, MD
20892, 301–435–0965, newmanla2@
mail.nih.gov.
This notice is being published less than 15
days prior to the meeting due to the timing
limitations imposed by the review and
funding cycle.
E:\FR\FM\07FEN1.SGM
07FEN1
Agencies
[Federal Register Volume 79, Number 26 (Friday, February 7, 2014)]
[Notices]
[Pages 7466-7467]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-02587]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Cancer Institute; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications/contract proposals and the
discussions could disclose confidential trade secrets or commercial
property such as patentable material, and personal information
concerning individuals associated with the grant applications, the
disclosure of which would constitute a clearly unwarranted invasion of
personal privacy.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus R03/R21: Tumor Immunology.
Date: March 5-6, 2014.
Time: 6:30 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Robert Bird, Ph.D., Chief, Resources and
Training Review Branch, Division of Extramural Activities, National
Cancer Institute, NIH, 9609 Medical Center Drive, Room 7W110,
Bethesda, MD 20892-8328, 240-276-6344, birdr@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; NCI Omnibus--Cancer Biology 1.
Date: March 6-7, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W242, Bethesda, MD 20892-9750, 240-276-6372,
zouzhiq@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Collaborative Research in Integrative Cancer Biology.
Date: March 13, 2014.
Time: 11:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W242, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Zhiqiang Zou, MD, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W242, Bethesda, MD 20892-9750, 240-276-6372,
zouzhiq@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Awards for Research on Imaging and Biomarkers for Early
Cancer Detection.
Date: March 17, 2014.
Time: 9:00 a.m. to 12:30 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 2W914, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Thomas A. Winters, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W412, Rockville, MD 20892-2750, 240-276-6386,
twinters@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Prevention.
Date: March 19, 2014.
Time: 7:30 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center 5701,
Marinelli Road, Bethesda, MD 20852.
Contact Person: Clifford Schweinfest, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W108, Bethesda, MD 20892-9750, 240-276-6343,
schweinfestcw@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Biosensor-Based Core Needles for Tumor Biopsy.
Date: March 19, 2014.
Time: 12:00 p.m. to 5:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4W032, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Donald L. Coppock, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center,
Room 7W260, Bethesda, MD 20892, 240-276-6382,
donald.coppock@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Omnibus--Drug Delivery/Imaging/Biotechnology.
Date: March 20-21, 2014.
Time: 7:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Courtyard Marriott Washingtonian Center, 204 Boardwalk
Place, Gaithersburg, MD 20878.
Contact Person: Gerald G. Lovinger, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W266, Rockville, MD 20850-9750, 240-276-6385,
lovingeg@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel, Cancer Therapy (Omnibus).
Date: March 27-28, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Gaithersburg Marriott Washingtonian Center, 9751
Washingtonian Boulevard, Gaithersburg, MD 20878.
Contact Person: Caron A Lyman, Ph.D., Chief, Research Programs
Review Branch, Division of Extramural Activities, National Cancer
Institute, NIH, 9609 Medical Center Drive, Room 7W126, Bethesda, MD
20892-9750, 240-276-6348, lymanc@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Drug Reformulation.
Date: March 27, 2014.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate contract proposals.
Place: Hilton Garden Inn Washington DC/Bethesda, 7301 Waverly
Street, Bethesda, MD 20814.
Contact Person: Thomas M. Vollberg, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W412, Bethesda, MD 20892-9750, 240-276-6341,
vollbert@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Career
[[Page 7467]]
Development Awards (PAR 12-050, PAR 12-062).
Date: April 1, 2014.
Time: 1:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 7W032, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Lynn M. Amende, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W112, Bethesda, MD 20892-9750, 240-276-6345,
amendel@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Career Development Awards (PAR 12-121).
Date: April 2, 2014.
Time: 12:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Cancer Institute Shady Grove, 9609 Medical
Center Drive, Room 4W032, Rockville, MD 20850, (Telephone Conference
Call).
Contact Person: Lynn M. Amende, Ph.D., Scientific Review
Officer, Resources and Training Review Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W112, Bethesda, MD 20892-9750, 240-276-6345,
amendel@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Biology-3.
Date: April 17-18, 2014.
Time: 5:00 p.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Bethesda North Marriott Hotel & Conference Center, 5701
Marinelli Road, Bethesda, MD 20852.
Contact Person: Viatcheslav A Soldatenkov, MD, Ph.D., Scientific
Review Officer, Special Review and Logistics Branch, Division of
Extramural Activities, National Cancer Institute, NIH, 9609 Medical
Center Drive, Room 7W254, Bethesda, MD 20892-8329, 240-276-6378,
soldatenkovv@mail.nih.gov.
Name of Committee: National Cancer Institute Special Emphasis
Panel; Cancer Detection, Diagnosis, and Treatment Technologies for
Global Health.
Date: April 29-30, 2014.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Washington/Rockville, 1750 Rockville Pike,
Rockville, MD 20852.
Contact Person: Adriana Stoica, Ph.D., Scientific Review
Officer, Special Review and Logistics Branch, Division of Extramural
Activities, National Cancer Institute, NIH, 9609 Medical Center
Drive, Room 7W234, Bethesda, MD 20892-9750, 240-276-6368,
Stoicaa2@mail.nih.gov.
Information is also available on the Institute's/Center's home
page: https://deainfo.nci.nih.gov/advisory/sep/sep.htm, where an
agenda and any additional information for the meeting will be posted
when available.
(Catalogue of Federal Domestic Assistance Program Nos. 93.392,
Cancer Construction; 93.393, Cancer Cause and Prevention Research;
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer
Control, National Institutes of Health, HHS)
Dated: February 3, 2014.
Melanie J. Gray,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2014-02587 Filed 2-6-14; 8:45 am]
BILLING CODE 4140-01-P